Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vocacapsaicin in abdominoplasty
NCT03789318Phase 2Completed
- Sponsor
- Concentric Analgesics, Inc.
- Start
- Dec 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Cauterex in Persistent postsurgical pain (PPSP) (5 arms), sponsored by Concentric Analgesics, Inc. Primary endpoint: Pain Intensity Scores at 96 Hours at Rest Using Numerical Rating Scale (NRS). Started Dec 2018; status: completed.
02
Drugs
Cauterex
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT03789318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789318.